Successful Treatment of Two Patients with Candida auris Candidemia with the Investigational Agent, Oral Ibrexafungerp (formerly SCY ‐078), from the CARES Study

Successful Treatment of Two Patients with Candida auris Candidemia with the Investigational Agent, Oral Ibrexafungerp (formerly SCY ‐078), from the CARES StudyConference abstracts

Source: The Aspergillus Website - updates - October 10, 2019 Category: Respiratory Medicine Authors: MeganB Source Type: news